Switzerland· 53609023
Rhophylac 300, Injektionslösung
A anti-d (rh) immunoglobulin product containing immunoglobulinum humanum anti-d, registered in Switzerland by CSL Behring AG and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 11 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Anti-d (rh) immunoglobulin is registered in 11 of 19 countries.
Countries holding a registration under ATC J06BB01 (anti-d (rh) immunoglobulin), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 7 of them publish a price we can compare per daily dose
Anti-d (rh) immunoglobulin · ATC J06BB01
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Swissmedic (Switzerland)- Active substance
- immunoglobulinum humanum anti-D
- Manufacturer
- CSL Behring AG
- Country
- Switzerland (CH)
- ATC code
- J06BB01
- ATC class
- Anti-D (rh) immunoglobulin
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin7680536090237Fertspr 2 mlCHF 87.9
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Anti-d (rh) immunoglobulin in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumImmunorho 300 µg/2 mlKedrion
- SpainRHOPHYLAC 300 microgramos / 2ml DE SOLUCION INYECTABLE EN JERINGA PRECARGADACsl Behring Gmbh
- PolandGamma anty-D 150Synthaverse S.A.
- United KingdomAnti-D (RHO) immunoglobulin 1,250units/1ml solution for injection pre-filled syringesBaxter Healthcare Ltd
- FinlandRhesonativOctapharma Ab
- NetherlandsRhesonativ 625 IE/ml, oplossing voor injectieOctapharma GmbH
- United StatesHYPERRHOGRIFOLS USA, LLC
- CzechiaIGAMADInstituto Grifols, S.A., Barcelona
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Rhesonativ, Rhophylac
- Belgium · Immunorho, Rhophylac
- Bulgaria · Резонатив
- Cyprus · Rhesonativ, Rhophylac
- Czechia · Igamad, Rhesonativ
- Germany · Rhesonativ, Rhophylac
- Denmark · Rhesonativ, Rhophylac
- Estonia · Rhesonativ
- Spain · Igamad, Rhophylac
- Finland · Rhophylac
- France · Rhesonativ, Rhophylac
- United Kingdom (Northern Ireland) · D-Gam, Rhophylac
- Greece · Rhophylac
- Hungary · Rhesonativ, Rhophylac
- Ireland · Rhophylac
- Iceland · Rhesonativ, Rhophylac
- Italy · Igamad, Immunorho
- Lithuania · Rhesonativ
- Luxembourg · Rhesonativ, Rhophylac
- Latvia · Rhesonativ
- Malta · Rhesonativ, Rhophylac
- Netherlands · Rhesonativ, Rhophylac
- Norway · Rhesonativ, Rhophylac
- Poland · Gamma Anty-D, Rhesonativ
- Portugal · Rhesonativ, Rhophylac
- Romania · Rhesonativ, Rhophylac
- Sweden · Rhesonativ, Rhophylac
- Slovenia · Rhesonativ, Rhophylac
- Slovakia · Igamad, Rhesonativ
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c7566b4b-647c-4a95-bff2-9f5c75f64696 GET /v1/drugs/c7566b4b-647c-4a95-bff2-9f5c75f64696?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "immunoglobulinum humanum anti-d 300 mcg",
"valid_from": "2002-01-01",
"limitations": null,
"galenic_form": "Inj Lös 300 mcg/2ml",
"therapeutic_area": null,
"sl_inclusion_date": "2002-01-01",
"self_retention_pct": 10
}See everything about anti-d (rh) immunoglobulin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.